WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for PASG

Based on 1 analyst offering 12 month price targets for Passage Bio Inc.
Min Forecast
$5.00+220.51%
Avg Forecast
$5.00+220.51%
Max Forecast
$5.00+220.51%

Should I buy or sell PASG stock?

Based on 1 analyst offering ratings for Passage Bio Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PASG stock forecasts and price targets.

PASG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is PASG forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.69%

Forecast return on assets

Is PASG forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PASG revenue forecast

What is PASG's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$11.1M
Avg 2 year Forecast
$34.2M
Avg 3 year Forecast
$5.9M

PASG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PASG$1.56$5.00+220.51%Buy
VINC$4.05$5.00+23.46%Strong Buy
SPRO$1.64$7.00+326.83%Buy
MURA$5.21N/AN/A
CLSD$1.40$6.00+330.11%Buy

Passage Bio Stock Forecast FAQ

Is Passage Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PASG) stock is to Buy PASG stock.

Out of 1 analyst, 0 (0%) are recommending PASG as a Strong Buy, 1 (100%) are recommending PASG as a Buy, 0 (0%) are recommending PASG as a Hold, 0 (0%) are recommending PASG as a Sell, and 0 (0%) are recommending PASG as a Strong Sell.

If you're new to stock investing, here's how to buy Passage Bio stock.

What is PASG's revenue growth forecast for 2025-2027?

(NASDAQ: PASG) Passage Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.2%.

Passage Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PASG's revenue for 2025 to be $608,497,982, with the lowest PASG revenue forecast at $608,497,982, and the highest PASG revenue forecast at $608,497,982. On average, 1 Wall Street analysts forecast PASG's revenue for 2026 to be $1,874,831,620, with the lowest PASG revenue forecast at $1,874,831,620, and the highest PASG revenue forecast at $1,874,831,620.

In 2027, PASG is forecast to generate $322,887,668 in revenue, with the lowest revenue forecast at $322,887,668 and the highest revenue forecast at $322,887,668.

What is PASG's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PASG) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PASG's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PASG price target, the average PASG price target is $5.00, with the highest PASG stock price forecast at $5.00 and the lowest PASG stock price forecast at $5.00.

The Wall Street analyst predicted that Passage Bio's share price could reach $5.00 by Nov 14, 2024. The average Passage Bio stock price prediction forecasts a potential upside of 220.51% from the current PASG share price of $1.56.

What is PASG's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PASG) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.